Search
for
Sort by
Research 331–360 of 1000+
- Androgen excess and post-reproductive health
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
- The Case of the Elusive Androgen
- Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium
- Serum Cystatin C levels in adolescent females: A comparative study between PCOS and Non-PCOS groups
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- Development and evaluation of cosmeceutical cream for acne vulgaris
- Evaluation of the Therapeutic Effect of Palash Basti in the Polyendocrine metabolic ovarian syndrome (PMOS): A Case Report
- Serum level of Apelin-12 in acne patients: Is it a marker of disease severity?
- Targets to treat androgen excess in polycystic ovary syndrome
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- The Role of Androgens in Health and Disease in Females: A Narratıve Review
- Androgen excess: a hallmark of polycystic ovary syndrome
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Androgen excess is the key element in polycystic ovary syndrome
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Regulatory roles of androgens in cutaneous wound healing
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Androgens Affect the Activity of Human Sebocytes in Culture in a Manner Dependent on the Localization of the Sebaceous Glands and Their Effect Is Antagonized by Spironolactone
- Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Androgen treatment of postmenopausal women
- A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Development of fluridil, a topical suppressor of the androgen receptor in androgenetic alopecia